Does International Normalized Ratio Level Predict Pulmonary Embolism?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Preventing pulmonary embolism is a priority after major musculoskeletal surgery. The literature contains discrepant data regarding the influence of anticoagulation on the incidence of pulmonary embolism after joint arthroplasty. The American College of Chest Physicians guidelines recommend administration of oral anticoagulants (warfarin), aiming for an international normalized ratio (INR) level between 2 and 3. However, recent studies show aggressive anticoagulation (INR > 2) can lead to hematoma formation and increased risk of subsequent infection.
We asked whether an INR greater than 2 protects against pulmonary embolism.
Patients and Methods
We identified 9112 patients with 10,122 admissions for joint arthroplasty between 2004 and 2008. All patients received warfarin for prophylaxis, aiming for an INR level of 2 or lower. We assessed 609 of 10,122 admissions (6%) for pulmonary embolism using CT, ventilation/perfusion scan, or pulmonary angiography, and 163 of 10,122 admissions (1.6%) had a proven pulmonary embolism.
Fifteen of 163 admissions (9%) had an INR greater than 2 before or on the day of workup compared to 35 of 446 admissions (8%) who were negative. We observed no difference between the INR values in patients with or without pulmonary embolism.
We found no clinically relevant difference in the INR values of patients who did or did not develop pulmonary embolism. The risk of bleeding should be weighed against the risk of pulmonary embolism when determining an appropriate target INR for each patient, as an INR less than 2 may reduce the risk of bleeding while still protecting against pulmonary embolism.
Level of Evidence
Level III, therapeutic study. See Instructions to Authors for a complete description of levels of evidence.
- Balderston, RA, Graham, TS, Booth, RE, Rothman, RH (1989) The prevention of pulmonary embolism in total hip arthroplasty: evaluation of low-dose warfarin therapy. J Arthroplasty. 4: pp. 217-221 CrossRef
- Callaghan, JJ, Dorr, LD, Engh, GA, Hanssen, AD, Healy, WL, Lachiewicz, PF, Lonner, JH, Lotke, PA, Ranawat, CS, Ritter, MA, Salvati, EA, Sculco, TP, Thornhill, TS (2005) Prophylaxis for thromboembolic disease: recommendations from the American College of Chest Physicians—are they appropriate for orthopaedic surgery?. J Arthroplasty. 20: pp. 273-274 CrossRef
- Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 40: pp. 373-383 CrossRef
- Clark, NP, Witt, DM, Delate, T, Trapp, M, Garcia, D, Ageno, W, Hylek, EM, Crowther, MA (2008) Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study. Pharmacotherapy. 28: pp. 960-967 CrossRef
- Deyo, RA, Cherkin, DC, Ciol, MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 45: pp. 613-619 CrossRef
- Dorr, LD, Gendelman, V, Maheshwari, AV, Boutary, M, Wan, Z, Long, WT (2007) Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. J Bone Joint Surg Am. 89: pp. 2648-2657 CrossRef
- Enyart, JJ, Jones, RJ (2005) Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery. Ann Pharmacother. 39: pp. 1002-1007 CrossRef
- Fitzgerald, RH, Spiro, TE, Trowbridge, AA, Gardiner, GA, Whitsett, TL, O’Connell, MB, Ohar, JA, Young, TR (2001) Prevention of venous thromboembolic disease following primary total knee arthroplasty: a randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am. 83: pp. 900-906
- Freedman, KB, Brookenthal, KR, Fitzgerald, RH, Williams, S, Lonner, JH (2000) A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 82: pp. 929-938
- Geerts, WH, Bergqvist, D, Pineo, GF, Heit, JA, Samama, CM, Lassen, MR, Colwell, CW (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 133: pp. 381S-453S CrossRef
- Johanson, NA, Lachiewicz, PF, Lieberman, JR, Lotke, PA, Parvizi, J, Pellegrini, V, Stringer, TA, Tornetta, P, Haralson, RH, Watters, WC (2009) American Academy of Orthopaedic Surgeons Clinical Practice Guideline on prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Bone Joint Surg Am. 91: pp. 1756-1757 CrossRef
- Mantilla, CB, Horlocker, TT, Schroeder, DR, Berry, DJ, Brown, DL (2002) Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 96: pp. 1140-1146 CrossRef
- Murray, DW, Britton, AR, Bulstrode, CJ (1996) Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg Br. 78: pp. 863-870 CrossRef
- O’Reilly, RF, Burgess, IA, Zicat, B (2005) The prevalence of venous thromboembolism after hip and knee replacement surgery. Med J Aust. 182: pp. 154-159
- Parvizi, J, Azzam, K, Rothman, RH (2008) Deep venous thrombosis prophylaxis for total joint arthroplasty: American Academy of Orthopaedic Surgeons guidelines. J Arthroplasty. 23: pp. 2-5 CrossRef
- Parvizi, J, Jacovides, CL, Bican, O, Purtill, JJ, Sharkey, PF, Hozack, WJ, Rothman, RH (2010) Is deep vein thrombosis a good proxy for pulmonary embolus?. J Arthroplasty. 25: pp. 138-144 CrossRef
- Pellegrini, VD, Sharrock, NE, Paiement, GD, Morris, R, Warwick, DJ (2008) Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment. Instr Course Lect. 57: pp. 637-661
- Phillips, CB, Barrett, JA, Losina, E, Mahomed, NN, Lingard, EA, Guadagnoli, E, Baron, JA, Harris, WH, Poss, R, Katz, JN (2003) Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am. 85: pp. 20-26 CrossRef
- Pulido, L, Parvizi, J, Macgibeny, M, Sharkey, PF, Purtill, JJ, Rothman, RH, Hozack, WJ (2008) In hospital complications after total joint arthroplasty. J Arthroplasty. 23: pp. 139-145 CrossRef
- Sharrock, NE, Gonzalez Della Valle, A, Go, G, Lyman, S, Salvati, EA (2008) Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res. 466: pp. 714-721 CrossRef
- Does International Normalized Ratio Level Predict Pulmonary Embolism?
Clinical Orthopaedics and Related Research®
Volume 470, Issue 2 , pp 547-554
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors